Article info
PDFMovement disorders
Research paper
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
- Correspondence to Dr Marina A J Tijssen, Universitair Medisch Centrum Groningen, 9713 GZ Groningen, The Netherlands; m.a.j.de.koning-tijssen{at}umcg.nl
Citation
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
Publication history
- Received December 16, 2018
- Revised May 15, 2019
- Accepted May 22, 2019
- First published June 20, 2019.
Online issue publication
December 12, 2019
Article Versions
- Previous version (10 October 2019).
- Previous version (10 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.